Max Chan

Directeur Financier/CFO chez FORESEE PHARMACEUTICALS CO., LTD.

Profil

Max Chan is currently a Member of the Supervisory Board at Wisepal Technologies, Inc., Harvest Investments Ltd., Himax Imaging Ltd., Himax Media Solutions, Inc., and Himax Semiconductor Ltd. Mr. Chan is the Chief Financial Officer at Himax Taiwan, Inc. Mr. Chan is the Head of Accounting at Eden Biologics, Inc. since 2018 and the Chief Financial Officer at Foresee Pharmaceuticals Co., Ltd. since 2019.
Former roles include Manager-Intel Capital Treasury at Intel Corp.
from 2004, Manager-Overseas Direct Investment Department at CDIB Capital Group in 2000, Chief Financial Officer at Himax Technologies, Inc. from 2004 to 2010, CFO and Head of Finance & Administration at TaiGen Biotechnology Co., Ltd. from 2012 to 2015, Senior Associate at Credit Suisse First Boston Asia International (Cayman) Ltd., and Deputy General Manager & Head of Finance at OBI Pharma, Inc. from 2010 to 2019.
Education includes graduate studies at the University of Illinois and undergraduate and MBA degrees from National Taiwan University.

Postes actifs de Max Chan

Sociétés	Poste	Début
JHL BIOTECH, INC.	Comptroller/Controller/Auditor	20/10/2015
FORESEE PHARMACEUTICALS CO., LTD.	Directeur Financier/CFO	07/10/2019
Himax Taiwan, Inc.	Directeur Financier/CFO	08/03/2010
Himax Media Solutions, Inc.	Directeur/Membre du Conseil	08/03/2010
Himax Imaging Ltd.	Directeur/Membre du Conseil	08/03/2010
Wisepal Technologies, Inc.	Directeur/Membre du Conseil	08/03/2010
Harvest Investments Ltd.	Directeur/Membre du Conseil	09/12/2010
Himax Semiconductor Ltd.	Directeur/Membre du Conseil	09/12/2010

Anciens postes connus de Max Chan

Sociétés	Poste	Fin
OBI PHARMA, INC.	Directeur Financier/CFO	01/01/2019
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░